tirzepatide breast cancer study and Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis Cancer: ENDO 2025 | Tirzepatide

Mounjaro's sales dip: How cheap generics are redrawing India's GLP-1 market The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive Eli Lilly's Mounjaro posted its first monthly sales drop in India in Marcha Rs 20-crore decline, from roughly Rs 135 crore in February to Rs 114 crorejust days after a clutch of Indian generics entered the country's booming GLP-1 market

Field excitatory postsynaptic potentials (fEPSPs) were obtained under the same conditions and using the same recording equipment as the patch-clamp recordings

Lifestyle Strategies to Optimize Natural GLP-1 Production Evidence-based interventions support sustainable GLP-1 activation without medication

Ce traitement optimise lhydratation, booste lnergie et favorise la rcupration du corps tout en renforant le systme immunitaire

Revisiting functional dysconnectivity: a review of three model frameworks in schizophrenia

Topiramates (brand name Topamax) weight loss potential was first observed in patients treated for epilepsy